USFDA gives green signal to four Indian manufacturing plants in 10 days

MUMBAI: India’s leading drug companies got clean chit regarding manufacturing in 10 days by the US Food and Drug Administration (USFDA). The decision comes at a time when supply-chain has been decreased due to the Covid-19 pandemic are causing drug shortages across the world.

Earlier on Monday, Lupin Limited, the third largest generic drug supplier in the US by prescriptions, and Dr Reddy’s Laboratories received establishment inspection reports (EIRs), indicating closure of investigation by the US drug regulator of their manufacturing plants. Lupin’s also received EIR facility in Central India’s Nagpur.

“We are very happy to have received the EIR for our Nagpur facility, our largest and most advanced oral solid dosage facility,” Lupin managing director Nilesh Gupta said.
The company got the EIR for its active pharmaceutical plant 5 at Miryalaguda in Telangana, said Hyderabad-based Dr Reddy in a statement.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • Health
    • June 11, 2025
    • 487 views
    Doctors trialling ‘poo pills’ to flush out dangerous superbugs

    UK doctors are attempting to clear dangerous superbug infections using “poo pills” containing freeze-dried faeces. The stool samples come from healthy donors and are packed with good bacteria. Early data…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July